In the United States, two drugs have been approved to treat female sexual interest/arousal disorder (FSIAD): Vyleesi (bremelanotide) and Addyi (flibanserin). Some people may refer to these as ...

James is the Managing Editor for Motley Fool Money, overseeing the production and quality of our editorial content. James has worked full-time for The Motley Fool since 2012. He's a personal ...

Whether you’re working on a gift registry for your wedding or just in the market for an upgrade, choosing new dishware can be difficult. Perhaps more important than the style and color, the material ...

The latest in an occasional AppleInsider feature, looking at the world of Apple-related crime. 13 people charged in federal "new age porch pirate" case At the end of February, federal prosecutors ...